DRAD
$4.33
Digirad
($.18)
(3.99%)
DRAD
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Friday
Nov 1
6:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when DRAD reports earnings?
Beat
Meet
Miss

Where is DRAD's stock price going from here?
Up
Flat
Down
Stock chart of DRAD
Analysts
Summary of analysts' recommendations for DRAD
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
DIGIRAD CORPORATION provides diagnostic nuclear and ultrasound imaging systems and services to physicians' offices, hospitals and other medical services providers for cardiac, vascular, and general imaging applications. Digirad's Cardius XPO line of nuclear imaging cameras use patented solid-state technology and unique multi head design for superior performance and advanced features for sharper digital images, faster processing, compact size, lighter weight for portability, ability to handle patients up to 500 pounds, and improved patient comfort compared to standard nuclear cameras. Digirad's 2020tc general-purpose nuclear imager has a small footprint and may also be configured for fixed or mobile use to supplement primary imaging. Digirad's installed base of equipment exceeds 550 systems; in addition, a mobile fleet of 164 nuclear and ultrasound imaging systems is being used in 22 states and the District of Columbia, primarily in the eastern, midwestern and southwestern United States.